Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive
- PMID: 21898504
- DOI: 10.1002/hep.24654
Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive
Abstract
The sequential algorithm for fibrosis evaluation (SAFE) and the Bordeaux algorithm (BA), which cross-check FibroTest with the aspartate aminotransferase-to-platelet ratio index (APRI) or FibroScan, are very accurate but provide only a binary diagnosis of significant fibrosis (SAFE or BA for Metavir F ≥ 2) or cirrhosis (SAFE or BA for F4). Therefore, in clinical practice, physicians have to apply the algorithm for F ≥ 2, and then, when needed, the algorithm for F4 ("successive algorithms"). We aimed to evaluate successive SAFE, successive BA, and a new, noninvasive, detailed classification of fibrosis. The study included 1785 patients with chronic hepatitis C, liver biopsy, blood fibrosis tests, and FibroScan (the latter in 729 patients). The most accurate synchronous combination of FibroScan with a blood test (FibroMeter) provided a new detailed (six classes) classification (FM+FS). Successive SAFE had a significantly (P < 10(-3) ) lower diagnostic accuracy (87.3%) than individual SAFE for F ≥ 2 (94.6%) or SAFE for F4 (89.5%), and required significantly more biopsies (70.8% versus 64.0% or 6.4%, respectively, P < 10(-3) ). Similarly, successive BA had significantly (P ≤ 10(-3) ) lower diagnostic accuracy (84.7%) than individual BA for F ≥ 2 (88.3%) or BA for F4 (94.2%), and required significantly more biopsies (49.8% versus 34.6% or 24.6%, respectively, P < 10(-3) ). The diagnostic accuracy of the FM+FS classification (86.7%) was not significantly different from those of successive SAFE or BA. However, this new classification required no biopsy.
Conclusion: SAFE and BA for significant fibrosis or cirrhosis are very accurate. However, their successive use induces a significant decrease in diagnostic accuracy and a significant increase in required liver biopsy. A new fibrosis classification that synchronously combines two fibrosis tests was as accurate as successive SAFE or BA, while providing an entirely noninvasive (0% liver biopsy) and more precise (six versus two or three fibrosis classes) fibrosis diagnosis.
Copyright © 2011 American Association for the Study of Liver Diseases.
Comment in
-
Diagnostic algorithms for liver fibrosis in hepatitis C: are they ready to avoid liver biopsy?Hepatology. 2012 Feb;55(2):652-3; author reply 653. doi: 10.1002/hep.25517. Hepatology. 2012. PMID: 22162013 No abstract available.
Similar articles
-
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.Liver Int. 2009 Nov;29(10):1507-15. doi: 10.1111/j.1478-3231.2009.02101.x. Epub 2009 Sep 2. Liver Int. 2009. PMID: 19725892
-
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.Aliment Pharmacol Ther. 2012 Jan;35(1):92-104. doi: 10.1111/j.1365-2036.2011.04897.x. Epub 2011 Oct 28. Aliment Pharmacol Ther. 2012. PMID: 22035045
-
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.Am J Gastroenterol. 2011 Jul;106(7):1255-63. doi: 10.1038/ajg.2011.100. Epub 2011 Apr 5. Am J Gastroenterol. 2011. PMID: 21468012 Clinical Trial.
-
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.Eur J Gastroenterol Hepatol. 2009 Jan;21(1):28-38. doi: 10.1097/MEG.0b013e32830cebd7. Eur J Gastroenterol Hepatol. 2009. PMID: 19060630 Review.
-
Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.Prescrire Int. 2010 Feb;19(105):38-42. Prescrire Int. 2010. PMID: 20455345 Review.
Cited by
-
Acoustic radiation force impulse elastography, FibroScan®, Forns' index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods.Mol Med Rep. 2015 Jun;11(6):4174-82. doi: 10.3892/mmr.2015.3299. Epub 2015 Feb 4. Mol Med Rep. 2015. PMID: 25651500 Free PMC article.
-
Two or more synchronous combination of noninvasive test to increase accuracy of liver fibrosis in chronic hepatitis C.Hepat Mon. 2012 May;12(5):355-6. doi: 10.5812/hepatmon.6229. Epub 2012 May 30. Hepat Mon. 2012. PMID: 22783350 Free PMC article. No abstract available.
-
Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients.J Clin Gastroenterol. 2013 May-Jun;47(5):457-60. doi: 10.1097/MCG.0b013e318266fe70. J Clin Gastroenterol. 2013. PMID: 23328300 Free PMC article.
-
Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.Dig Dis Sci. 2023 Dec;68(12):4485-4498. doi: 10.1007/s10620-023-08085-y. Epub 2023 Sep 21. Dig Dis Sci. 2023. PMID: 37733130
-
Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls.BMC Gastroenterol. 2022 Jan 29;22(1):37. doi: 10.1186/s12876-022-02108-0. BMC Gastroenterol. 2022. PMID: 35090390 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical